Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination

被引：4
|
作者：
Tjan, Lidya Handayani [1 ]
Furukawa, Koichi [1 ]
Kurahashi, Yukiya [1 ]
Sutandhio, Silvia [1 ]
Nishimura, Mitsuhiro [1 ]
Arii, Jun [1 ]
Mori, Yasuko [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Div Clin Virol, Kobe, Hyogo, Japan
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 226卷 / 08期
关键词：
D O I：
10.1093/infdis/jiac159
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1481 / 1483
页数：3
相关论文
共 50 条
  • [21] Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster
    Ofra Amir
    Yair Goldberg
    Micha Mandel
    Yinon M. Bar-On
    Omri Bodenheimer
    Laurence Freedman
    Sharon Alroy-Preis
    Nachman Ash
    Amit Huppert
    Ron Milo
    Communications Biology, 6
  • [22] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Franck Touret
    Cécile Baronti
    Boris Pastorino
    Paola Mariela Saba Villarroel
    Laetitia Ninove
    Antoine Nougairède
    Xavier de Lamballerie
    Scientific Reports, 12
  • [23] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Touret, Franck
    Baronti, Cecile
    Pastorino, Boris
    Villarroel, Paola Mariela Saba
    Ninove, Laetitia
    Nougairede, Antoine
    de Lamballerie, Xavier
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
    Yu, Jingyou
    Collier, Ai-ris Y.
    Rowe, Marjorie
    Mardas, Fatima
    Ventura, John D.
    Wan, Huahua
    Miller, Jessica
    Powers, Olivia
    Chung, Benjamin
    Siamatu, Mazuba
    Hachmann, Nicole P.
    Surve, Nehalee
    Nampanya, Felix
    Chandrashekar, Abishek
    Barouch, Dan H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16):
  • [25] Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination
    Pedersen, Rune M.
    Bang, Line L.
    Madsen, Lone W.
    Sydenham, Thomas V.
    Johansen, Isik S.
    Jensen, Thoger G.
    Justesen, Ulrik S.
    Andersen, Thomas E.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1274 - 1275
  • [26] COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status
    Butt, Adeel A.
    Dargham, Soha R.
    Coyle, Peter
    Yassine, Hadi M.
    Al-Khal, Abdullatif
    Abou-Samra, Abdul-Badi
    Abu-Raddad, Laith J.
    JAMA INTERNAL MEDICINE, 2022, 182 (10) : 1097 - 1099
  • [27] Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 booster
    Amir, Ofra
    Goldberg, Yair
    Mandel, Micha
    Bar-On, Yinon M.
    Bodenheimer, Omri
    Freedman, Laurence
    Alroy-Preis, Sharon
    Ash, Nachman
    Huppert, Amit
    Milo, Ron
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [28] Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
    Dimeglio, Chloe
    Migueres, Marion
    Bouzid, Naemie
    Chapuy-Regaud, Sabine
    Gernigon, Caroline
    Da-Silva, Isabelle
    Porcheron, Marion
    Martin-Blondel, Guillaume
    Herin, Fabrice
    Izopet, Jacques
    VACCINES, 2022, 10 (09)
  • [29] Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
    Planchais, Cyril
    Fernandez, Ignacio
    Bruel, Timothee
    de Melo, Guilherme Dias
    Prot, Matthieu
    Beretta, Maxime
    Guardado-Calvo, Pablo
    Dufloo, Jeremy
    Molinos-Albert, Luis M.
    Backovic, Marija
    Chiaravalli, Jeanne
    Giraud, Emilie
    Vesin, Benjamin
    Conquet, Laurine
    Grzelak, Ludivine
    Planas, Delphine
    Staropoli, Isabelle
    Guivel-Benhassine, Florence
    Hieu, Thierry
    Boulle, Mikael
    Cervantes-Gonzalez, Minerva
    Ungeheuer, Marie-Noelle
    Charneau, Pierre
    van Der Werf, Sylvie
    Agou, Fabrice
    Dimitrov, Jordan D.
    Simon-Loriere, Etienne
    Bourhy, Herve
    Montagutelli, Xavier
    Rey, Felix A.
    Schwartz, Olivier
    Mouquet, Hugo
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (07):
  • [30] Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
    Jing Zou
    Chaitanya Kurhade
    Hongjie Xia
    Mingru Liu
    Xuping Xie
    Ping Ren
    Pei-Yong Shi
    Nature Communications, 13
12345